Summit Therapeutics Inc. Common Stock monthly returns
Summit Therapeutics Inc. Common Stock has averaged 4.92% a month with dividends reinvested, and risen in 44% of months, through November 17, 2026. The table lists the most recent months; the chart, the last 5 years.
Month by month#
Data provided bySource: Twelve Data| Month | Path | Total return |
|---|---|---|
| Nov 2026 | -33.4% | |
| Oct 2026 | -5.2% | |
| Sep 2026 | +24.2% | |
| Aug 2026 | +4.6% | |
| Jul 2026 | -10.6% | |
| Jun 2026 | -16.9% | |
| May 2026 | -18.3% | |
| Apr 2026 | +13.2% | |
| Mar 2026 | +14.3% | |
| Feb 2026 | +14.6% | |
| Jan 2026 | -17.2% | |
| Dec 2025 | -2.2% | |
| Nov 2025 | -5.4% | |
| Oct 2025 | -8.5% | |
| Sep 2025 | -12.8% | |
| Aug 2025 | -10.1% | |
| Jul 2025 | +23.9% | |
| Jun 2025 | +16.8% | |
| May 2025 | -24.5% | |
| Apr 2025 | +25.0% | |
| Mar 2025 | -6.8% | |
| Feb 2025 | -3.8% | |
| Jan 2025 | +20.5% | |
| Dec 2024 | -3.3% | |
| Nov 2024 | -0.7% | |
| Oct 2024 | -15.1% | |
| Sep 2024 | +68.7% | |
| Aug 2024 | +20.2% | |
| Jul 2024 | +38.5% | |
| Jun 2024 | -10.2% | |
| May 2024 | +121.0% | |
| Apr 2024 | -5.1% | |
| Mar 2024 | -8.8% | |
| Feb 2024 | +15.8% | |
| Jan 2024 | +50.2% | |
| Dec 2023 | +28.6% | |
| Nov 2023 | +4.6% | |
| Oct 2023 | +3.7% | |
| Sep 2023 | +15.4% | |
| Aug 2023 | -22.9% | |
| Jul 2023 | -16.3% | |
| Jun 2023 | +54.0% | |
| May 2023 | +23.5% | |
| Apr 2023 | -24.6% | |
| Mar 2023 | -2.8% | |
| Feb 2023 | -49.3% | |
| Jan 2023 | -16.5% | |
| Dec 2022 | +431.3% | |
| Nov 2022 | -26.6% | |
| Oct 2022 | -8.4% | |
| Sep 2022 | -0.8% | |
| Aug 2022 | +18.8% | |
| Jul 2022 | +1.0% | |
| Jun 2022 | -24.8% | |
| May 2022 | -16.4% | |
| Apr 2022 | -35.1% | |
| Mar 2022 | -10.6% | |
| Feb 2022 | +24.5% | |
| Jan 2022 | -18.2% | |
| Dec 2021 | -47.0% | |
| Nov 2021 | -1.6% | |
| Oct 2021 | +3.0% | |
| Sep 2021 | -37.1% | |
| Aug 2021 | +8.7% | |
| Jul 2021 | -1.7% | |
| Jun 2021 | -4.6% | |
| May 2021 | +22.8% | |
| Apr 2021 | +8.5% | |
| Mar 2021 | -13.3% | |
| Feb 2021 | -2.7% | |
| Jan 2021 | +48.1% | |
| Dec 2020 | +4.4% | |
| Nov 2020 | +37.6% | |
| Oct 2020 | -4.9% | |
| Sep 2020 | -0.3% | |
| Aug 2020 | -4.7% | |
| Jul 2020 | +21.9% | |
| Jun 2020 | -26.5% | |
| May 2020 | +7.7% | |
| Apr 2020 | +58.2% | |
| Mar 2020 | +71.7% | |
| Feb 2020 | -9.8% | |
| Jan 2020 | -4.4% | |
| Dec 2019 | +6.7% | |
| Nov 2019 | -9.1% | |
| Oct 2019 | -7.8% | |
| Sep 2019 | +33.9% | |
| Aug 2019 | +1.3% | |
| Jul 2019 | +4.3% | |
| Jun 2019 | -16.8% | |
| May 2019 | -13.9% | |
| Apr 2019 | -3.6% | |
| Mar 2019 | -20.4% | |
| Feb 2019 | +72.9% | |
| Jan 2019 | +15.7% | |
| Dec 2018 | -11.5% | |
| Nov 2018 | -23.5% | |
| Oct 2018 | -23.4% | |
| Sep 2018 | -5.5% | |
| Aug 2018 | +2.2% | |
| Jul 2018 | -6.1% | |
| Jun 2018 | -81.6% | |
| May 2018 | +2.5% | |
| Apr 2018 | +1.0% | |
| Mar 2018 | +10.2% | |
| Feb 2018 | -14.7% | |
| Jan 2018 | +23.9% | |
| Dec 2017 | -5.9% | |
| Nov 2017 | +14.5% | |
| Oct 2017 | -18.1% | |
| Sep 2017 | -2.5% | |
| Aug 2017 | -7.9% | |
| Jul 2017 | +22.7% | |
| Jun 2017 | +2.4% | |
| May 2017 | +1.1% | |
| Apr 2017 | -17.1% | |
| Mar 2017 | +8.7% | |
| Feb 2017 | +16.6% | |
| Jan 2017 | +22.3% | |
| Dec 2016 | -18.4% |
Monthly total return (since Dec 2021)#
Summit Therapeutics Inc. Common Stock returns by calendar month#
Every month of every year since 2015, one tick per year on a shared scale; the dark bar is the month's average. Total returns, dividends reinvested.
November 2026 so far: -33.44% — 12th of 12 Novembers since 2015 at the last close; the average November returned -1.6%.
| Month | −435%0+435% | Average | Median | Up | Best | Worst |
|---|---|---|---|---|---|---|
| Jan | +9.3% | +15.7% | 55% | +50.2% 2024 | -21.7% 2016 | |
| Feb | +3.6% | -2.7% | 45% | +72.9% 2019 | -49.3% 2023 | |
| Mar | +3.9% | -2.8% | 45% | +71.7% 2020 | -20.4% 2019 | |
| Apr | +4.3% | -1.3% | 50% | +58.2% 2020 | -35.1% 2022 | |
| May | +7.6% | +0.3% | 50% | +121.0% 2024 | -24.5% 2025 | |
| Jun | -9.4% | -8.1% | 33% | +54.0% 2023 | -81.6% 2018 | |
| Jul | +7.2% | +2.7% | 58% | +38.5% 2024 | -16.3% 2023 | |
| Aug | -0.3% | -1.7% | 50% | +20.2% 2024 | -22.9% 2023 | |
| Sep | +8.9% | -0.6% | 42% | +68.7% 2024 | -37.1% 2021 | |
| Oct | -4.8% | -6.5% | 25% | +29.9% 2016 | -23.4% 2018 | |
| Nov | -1.6% | -1.6% | 36% | +37.6% 2020 | -26.6% 2022 | |
| Dec | +35.7% | -2.2% | 45% | +431.3% 2022 | -47.0% 2021 |
Methodology#
Monthly returns are total returns (dividends reinvested), computed from SMMT's split- and dividend-adjusted month-end closes. The table shows the most recent 120 months and the bar chart the most recent 60. See the year-by-year returns for the annual view. Past performance does not predict future returns; not investment advice.
FAQ#
- What is Summit Therapeutics Inc. Common Stock's average monthly return?
- Summit Therapeutics Inc. Common Stock has averaged about 4.92% per month (dividends reinvested), positive in roughly 44% of months. The best month was Dec 2022 (+431.3%) and the worst was Jun 2018 (-81.6%).
